ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Glenmark Pharmaceuticals, INC.

Official 2024 U.S. DOL Form 5500 summary for Glenmark Pharmaceuticals, INC. (Glenmark Pharmaceuticals, INC. 401(k) Plan · EIN 75-3102019 · PN 001): $26.87M net assets, 226 active participants, and $58.92 per $10,000 (58.92 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorGlenmark Pharmaceuticals, INC.
Filing IdentifierGlenmark Pharmaceuticals, INC. 401(k) Plan · EIN 75-3102019 · PN 001
Plan Category & State401(k) Defined Contribution (NJ)
Asset-Size Peer Cohort$5M-$25M
Plan Net Assets (2024)$26.87M
Active Participants226
Direct Admin Fee Rate$58.92 per $10,000 (58.92 bps)
Cohort Peer Median$37.06 per $10,000 (37.06 bps)
Primary Recordkeeper / ProviderEmpower Retirement
Schedule H Line 4a RemittanceSchedule H Line 4a Late Remittance Reported ($94,397, often administrative timing)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI